Advancing Vaccines in the Genomics Era Organizer(s): Bali Pulendran, Chris Wilson and Rino Rappuoli Date: October 31 - November 04, 2013
Location: Windsor Barra Hotel, Rio de Janeiro, Barra da Tijuca, Rio de Janeiro, BrazilA direct consequence of the Human Genome Project has been the development of so-called “omic” technologies (e.g. genomics, proteomics) that can be used to probe the molecular networks that control biological systems. Such technologies are beginning to be applied to vaccinology to obtain deeper insights about the molecular networks that orchestrate protective immunity induced by vaccination in humans. Such systems biological approaches are enhancing our understanding of the correlates of protective immunities, of the early innate immune signatures of vaccine efficacy, and guiding the rational design of novel and safer vaccines and adjuvants. This meeting will explore the potential of systems biology in vaccine design and development. Participants will include vaccinologists, immunologists, virologists, microbiologists, scientists using systems approaches in other areas of biomedical research, as well as individuals working in industry and health policy who are interested in the potential of genomics in vaccinology. The meeting will address how systems biology has provided insight into the immune response to vaccines, and will also discuss the technical and bioinformatic challenges associated with using systems biology approaches. Researchers will show 'systems vaccinology' approaches can be implemented in vaccine development and clinical trial monitoring. Global Health Travel Award Deadline: June 4 2013 Scholarship Deadline: June 27 2013 Discounted Abstract Deadline: June 27 2013 Abstract Deadline: July 30 2013 Discounted Registration Deadline: August 29 2013 We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Dynavax Technologies Corporation
Novartis Vaccines and Diagnostics
We gratefully acknowledge the generous grant for this conference provided by: National Institute of Allergy and Infectious Diseases (NIAID)Grant No. 1R13AI108157-01 The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |